Cinthia Travaglini
Head of Clinical Supply Chain | UCB
Cinthia Travaglini represents UCB, a global biopharmaceutical company with strong roots in Belgium and a focus on severe diseases, including neurological conditions.
In the Thursday session 'When a breakthrough has only 48 hours to save a life', she brings the perspective of a company working on therapies that are becoming increasingly specific, time-sensitive and complex. Her contribution shows why logistics needs to be considered from the start of the innovation process, especially when therapies move across continents and need to reach the patient within extremely tight time windows.
A line-up of human-centric innovators
These extraordinary technology experts know their way around the latest innovations, but they always keep in mind that we're extra ordinary first.
